Molecular basis of venous insufficiency

The Vein Book

Volumn , Issue , 2007, Pages 67-78

  Schmid Schönbein, Geert W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 46749090667     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-012369515-4/50010-7     Document Type: Chapter

References (148)

1. Leu AJ, Leu HJ, Franzeck UK, Bollinger A. Microvascular changes in chronic venous insufficiency-a review. Cardiovasc Surg. 1995, 3:237-245.
2. Bollinger A, Leu AJ, Hoffmann U, Franzeck UK. Microvascular changes in venous disease: An update. Angiology. 1997, 48:27-32.
3. Van Cleef JF, Desvaux P, Hugentobler JP, et al. Étude endoscopique des reflux valvulaires sapheniens. J Mal Vasc. 1992, 17:113-116.
4. Blanchemaison P Interet de L'endoscopie veineuse dans l'explora- tion et le traitement de l'insuffisance veineuse des membres inferieurs. J Mal Vasc. 1992, 17:109-112.
5. Ono T, Bergan JJ, Schmid-Schönbein GW, Takase S. Monocyte infiltration into venous valves. J Vasc Surg. 1998, 27:158-166.
6. Takase S, Schmid-Schönbein G, Bergan JJ. Leukocyte activation in patients with venous insufficiency. J Vasc Surg. 1999, 30:148-156.
7. Al-Naemi H, Baldwin AL. Nitric oxide protects venules against histamine-induced leaks. Microcirculation. 2000, 7:215-223.
8. Waschke J, Burger S, Curry FR, Drenckhahn D, Adamson RH. Activation of Rac-1 and Cdc42 stabilizes the microvascular endothe-lial barrier. Histochem Cell Biol. 2005, 1-10.
9. Curry FE, Zeng M, Adamson RH. Thrombin increases permeability only in venules exposed to inflammatory conditions. Am J Physiol Heart Circ Physiol. 2003, 285:2446-2453.
10. Feng D, Nagy JA, Hipp J, Dvorak HF, Dvorak AM. Vesiculo-vacuolar organelles and the regulation of venule permeability to macromolecules by vascular permeability factor, histamine and serotonin. J Exp Med. 1996, 183:1981-1986.
11. Baldwin AL, Thurston G. Changes in endothelial actin cytoskeleton in venules with time after histamine treatment. Am J Physiol. 1995, 269:1528-1537.
12. Svensjo E, Joyner WL. The effects of intermittent and continuous stimulation of microvessels in the cheek pouch of hamsters with histamine and bradykinin on the development of venular leaky sites. Microcirc Endothelium Lymphatics. 1984, 1:381-396.
13. McDonald DM, Thurston G, Baluk P. Endothelial gaps as sites for plasma leakage in inflammation. Microcirculation. 1999, 6:7-22.
14. Baluk P, Hirata A, Thurston G, Fujiwara T, Neal CR, Michel CC, McDonald DM. Endothelial gaps: Time course of formation and closure in inflamed venules of rats. Am J Physiol. 1997, 272:155-170.
15. Michel CC, Kendall S. Differing effects of histamine and serotonin on microvascular permeability in anaesthetized rats. J Physiol. 1997, 501:657-662. Pt 3.
16. Corada M, Mariotti M, Thurston G, Smith K, Kunkel R, Brockhaus M, et al. Vascular endothelial-cadherin is an important determinant of microvascular integrity in vivo. Proc Natl Acad Sci USA. 1999, 96:9815-9820.
17. Huxley VH, Williams DA. Role of a glycocalyx on coronary arteriole permeability to proteins: Evidence from enzyme treatments. Am J Physiol Heart Circ Physiol. 2000, 278:1177-1185.
18. Thurston G, Baluk P, McDonald DM. Determinants of endothelial cell phenotype in venules. Microcirculation. 2000, 7:67-80.
19. Laughlin MH, McAllister RM, Jasperse JL, Crader SE, Williams DA, Huxley VH Endothelium-medicated control of the coronary circula-tion. Exercise training-induced vascular adaptations. Sports Med. 1996, 22:228-250.
20. Mannello F, Tonti GA, Bagnara GP, Papa S Role and function of matrix metalloproteinases in the differentiation and biological charac-terization of mesenchymal stem cells. Stem Cells. 2006, 24:475-481.
21. Jacob MP, Badier-Commander C, Fontaine V, Benazzoug Y, Feldman L, Michel JB. Extracellular matrix remodeling in the vascular wall. Pathol Biol (Paris) 2001, 49:326-332.
22. Lees M, Taylor DJ, Woolley DE. Mast cell proteinases activate precursor forms of collagenase stromelysin. Eur J Biochem. 1994, 223:171-177.
23. Sun HB, Smith GN, Hasty KA, Yokota H. Atomic force micros-copy-based detection of binding and cleavage site of matrix metal-loproteinase on individual type II collagen helices. Anal Biochem. 2000, 283:153-158.
24. Trengove NJ, Stacey MC, MacAuley S, Bennett N, Gibson J, Burslem F, et al. Analysis of the acute and chronic wound environments: The role of proteases and their inhibitors. Wound Repair Regen. 1999, 7:442-452.
25. Asanuma K, Magid R, Johnson C, Nerem RM, Galis ZS. Uniaxial strain upregulates matrix-degrading enzymes produced by human vascular smooth muscle cells. Am J Physiol Heart Circ Physiol. 2003, 284:1778-1784.
26. Kang T, Yi J, Guo A, Wang X, Overall CM, Jiang W, et al. Subcel-lular distribution and cytokine-and chemokine-regulated secretion of leukolysin/MT6-MMP/MMP-25 in neutrophils. J Biol Chem. 2001, 276:21960-21968.
27. Liu Z, Zhou X, Shapiro SD, Shipley JM, Twining SS, Diaz LA, et al. The serpin alpha1-proteinase inhibitor is a critical substrate for gel-atinase B/MMP-9 in vivo. Cell. 2000, 102:647-655.
28. Velasco G, Cal S, Merlos-Suarez A, Ferrando AA, Alvarez S, Nakano A, et al. Human MT6-matrix metalloproteinase: Identification proge-latinase A activation and expression in brain tumors. Cancer Res. 2000, 60:877-882.
29. Norgauer J, Hildenbrand T, Idzko M, Panther E, Bandemir E, Hartmann M, et al. Elevated expression of extracellular matrix metal-loproteinase inducer (CD147) and membrane-type matrix metallopro-teinases in venous leg ulcers. Br J Dermatol. 2002, 147:1180-1186.
30. Herouy Y, May AE, Pornschlegel G, Stetter C, Grenz H, Preissner KT, et al. Lipodermatosclerosis is characterized by elevated expres-sion and activation of matrix metalloproteinases: Implications for venous ulcer formation. J Invest Dermatol. 1998, 111:822-827.
31. Woodside KJ, Hu M, Burke A, Murakami M, Pounds LL, Killewich LA, et al. Morphologic characteristics of varicose veins: possible role of metalloproteinases. J Vasc Surg. 2003, 38:162-169.
32. Saito S, Trovato MJ, You R, Lal BK, Fasehun F, Padberg FT, Role of matrix metalloproteinases 1.2, et al. and 9 and tissue inhibi-tor of matrix metalloproteinase-1 in chronic venous insufficiency. J Vasc Surg. 2001, 34:930-938.
33. Vaalamo M, Mattila L, Johansson N, Kariniemi AL, Karjalainen-Lindsberg ML, Kahari VM, Saarialho-Kere U Distinct popula-tions of stromal cells express collagenase-3 (MMP-13) and collagenase-1 (MMP-1) in chronic ulcers but not in normally healing wounds. J Invest Dermatol. 1997, 109:96-101.
34. Fray MJ, Dickinson RP, Huggins JP, Occleston NL A potent, selective inhibitor of matrix metalloproteinase-3 for the topical treatment of chronic dermal ulcers. J Med Chem. 2003, 46:3514-3525.
35. Tarlton JF, Bailey AJ, Crawford E, Jones D, Moore K, Harding KD. Prognostic value of markers of collagen remodeling in venous ulcers. Wound Repair Regen. 1999, 7:347-355.
36. Zamboni P, Scapoli G, Lanzara V, Izzo M, Fortini P, Legnaro R, et al. Serum iron and matrix metalloproteinase-9 variations in limbs affected by chronic venous disease and venous leg ulcers. Dermatol Surg. 2005, 31:644-649. discussion 649.
37. Mwaura B, Mahendran B, Hynes N, Defreitas D, Avalos G, Adegbola T, et al. The impact of differential expression of extracellular matrix metalloproteinase inducer matrix metalloproteinase-2 tissue inhibi-tor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Eur J Vasc Endovasc Surg. 2005.
38. Wilms H, DeLano FA, Schmid-Schönbein GW. Microvascular hemorrhage and parenchymal cell injury in-vivo. Microcirculation. 2000, 7:41-52.
39. Ackerman Z, Loewenthal E, Seidenbaum M, Rubinow A, Gorodetsky R. Skin zinc concentrations in patients with varicose ulcers. Int J Dermatol. 1990, 29:360-362.
40. Ackerman Z, Seidenbaum M, Loewenthal E, Rubinow A. Overload of iron in the skin of patients with varicose ulcers. Possible contribut-ing role of iron accumulation in progression of the disease. Arch Dermatol. 1988, 124:1376-1378.
41. Yeoh-Ellerton S, Stacey MC. Iron and 8-isoprostane levels in acute and chronic wounds. J Invest Dermatol. 2003, 121:918-925.
42. Wenk J, Foitzik A, Achterberg V, Sabiwalsky A, Dissemond J, Meewes C, et al. Selective pick-up of increased iron by deferoxamine-coupled cellulose abrogates the iron-driven induction of matrix-degrading metalloproteinase 1 and lipid peroxidation in human dermal fibroblasts in vitro: A new dressing concept. J Invest Dermatol. 2001, 116:833-839.
43. Zamboni P, Tognazzo S, Izzo M, Pancaldi F, Scapoli GL, Liboni A, Gemmati D. Hemochromatosis C282Y gene mutation increases the risk of venous leg ulceration. J Vasc Surg. 2005, 42:309-314.
44. Ercan E, Tengiz I, Duman C, Sekuri C, Aliyev E, Mutlu B, et al. Decreased plasminogen activator inhibitor-1 levels in coronary artery aneurysmatic patients. J Thromb Thrombolysis. 2004, 17:207-211.
45. Rosario HS, Waldo SW, Becker SA, Schmid-Schönbein GW. Pan-creatic trypsin increases matrix metalloproteinase-9 accumulation and activation during acute intestinal ischemia-reperfusion in the rat. Am J Pathol. 2004, 164:1707-1716.
46. Helmke BP, Bremner SN, Zweifach BW, Skalak R, Schmid-Schönbein GW. Mechanisms for increased blood flow resistance due to leukocytes. Am J Physiol. 1997, 273:2884-2890.
47. Fukuda S, Yasu T, Kobayashi N, Ikeda N, Schmid-Schönbein GW. Contribution of fluid shear response in leukocytes to hemodynamic resistance in the spontaneously hypertensive rat. Circ Res. 2004, 95:100-108.
48. Moyses C, Cederholm-Williams SA, Michel CC. Haemoconcentra-tion and accumulation of white cells in the feet during venous stasis. Int J Microcirc Clin Exp. 1987, 5:311-320.
49. Thomas PRS, Nash GB, Dormandy JA. White cell accumulation in dependent legs of patients with venous hypertension: A possible mechanism for trophic changes in the skin. Brit Med J. 1988, 296:1693-1695.
50. Coleridge Smith PD, Thomas P, Scurr JH, Dormandy JA. Causes of venous ulceration: A new hypothesis. Brit Med J. 1988, 296:1726-1727.
51. Schmid-Schönbein GW, Lee J. Leukocytes in capillary flow. Int J Microcirc Clin Exp. 1995, 15:255-264.
52. Pappas PJ, Fallek SR, Garcia A, Araki CT, Back TL, Duran WN, Hobson RW. Role of leukocyte activation in patients with venous stasis ulcers. J Surg Res. 1995, 59:553-559.
53. Eriksson EE, Karlof E, Lundmark K, Rotzius P, Hedin U, Xie X. Powerful inflammatory properties of large vein endothelium in vivo. Arterioscler Thromb Vasc Biol. 2005, 25:723-728.
54. Yurdakul AS, Taci Hoca N, Cimen F, Balci M, Atikcan S. Circulat-ing adhesion molecules in patients with chronic obstructive pulmo-nary disease. Tuberk Toraks. 2004, 52:356-362.
55. Boucaud D, Lestage B, Boisseau MR. Changes in VCAM-1 cell adhesion molecule after phlebologic thermal care in chronic venous insufficiency of the lower limbs. J Mal Vasc. 2001, 26:327-328.
56. Shields DA, Andaz SK, Abeysinghe RD, Porter JB, Scurr JH, Coleridge-Smith PD. Plasma lactoferrin as a marker of white cell degranulation in venous disease. Phlebology. 1994, 9:55-58.
57. Shields DA, Andaz S, Sarin S, Scurr JH, Coleridge-Smith PD. Neu-trophil activation in experimental venous hypertension. Phlebologie. 1993, 46:687-689.
58. Shields DA, Andaz SK, Sarin S, Scurr JH, Coleridge Smith PD. Plasma elastase in venous disease. Br J Surg. 1994, 81:1496-1499.
59. Pappas PJ, Teehan EP, Fallek SR, Garcia A, Araki CT, Back TL, et al. Diminished mononuclear cell function is associated with chronic venous insufficiency. J Vasc Surg. 1995, 22:580-586.
60. Wilkinson LS, Bunker C, Edwards JC, Scurr JH, Smith PD. Leuko-cytes: Their role in the etiopathogenesis of skin damage in venous disease. J Vasc Surg. 1993, 17:669-675.
61. Pappas PJ, DeFouw DO, Venezio LM, Gorti R, Padberg FT, Silva MB, et al. Morphometric assessment of the dermal microcircula-tion in patients with chronic venous insufficiency. J Vasc Surg. 1997, 26:784-795.
62. Lalka SG, Unthank JL, Nixon JC. Elevated cutaneous leukocyte con-centration in a rodent model of acute venous hypertension. J Surg Res. 1998, 74:59-63.
63. Takase S, Lerond L, Bergan JJ, Schmid-Schönbein GW. The inflam-matory reaction during venous hypertension in the rat. Microcircula-tion. 2000, 7:41-52.
64. Hahn TL, Unthank JL, Lalka SG. Increased hindlimb leukocyte concentration in a chronic rodent model of venous hypertension. J Surg Res. 1999, 81:38-41.
65. Takase S, Bergan JJ, Schmid-Schönbein G. Expression of adhesion molecules and cytokines on saphenous veins in chronic venous insuf-ficiency. Ann Vasc Surg. 2000, 14:427-435.
66. Peschen M, Lahaye T, Hennig B, Weyl A, Simon JC, Vanscheidt W. Expression of the adhesion molecules ICAM-1 VCAM-1 LFA-1 and VLA-4 in the skin is modulated in progressing stages of chronic venous insufficiency. Acta Derm Venereol. 1999, 79:27-32.
67. Saharay M, Shields DA, Georgiannos SN, Porter JB, Scurr JH, Coleridge Smith PD. Endothelial activation in patients with chronic venous disease. Eur J Vasc Endovasc Surg. 1998, 15:342-349.
68. Weyl A, Vanscheidt W, Weiss JM, Peschen M, Schopf E, Simon J. Expression of the adhesion molecules ICAM-1 VCAM-1 and E-selectin and their ligands VLA-4 and LFA-1 in chronic venous leg ulcers. J Am Acad Dermatol. 1996, 34:418-423.
69. Saharay M, Shields DA, Porter JB, Scurr JH, Coleridge Smith PD. Leukocyte activity in the microcirculation of the leg in patients with chronic venous disease. J Vasc Surg. 1997, 26:265-273.
70. Quatresooz P, Henry F, Paquet P, Pierard-Franchimont C, Harding K, Pierard GE. Deciphering the impaired cytokine cascades in chronic leg ulcers (review). Int J Mol Med. 2003, 11:411-418.
71. Peschen M. Cytokines in progressing stages of chronic venous insuf-ficiency. Curr Probl Dermatol. 1999, 27:13-19.
72. Murphy MA, Joyce WP, Condron C, Bouchier-Hayes D. A reduction in serum cytokine levels parallels healing of venous ulcers in patients undergoing compression therapy. Eur J Vasc Endovasc Surg. 2002, 23:349-352.
73. Burnand KG, Whimster I, Clemenson G, Thomas ML, Browse NL. The relationship between the number of capillaries in the skin of the venous ulcer-bearing area of the lower leg and the fall in foot vein pressure during exe. Br J Surg. 1981, 68:297-300.
74. Junger M, Hahn U, Bort S, Klyscz T, Hahn M, Rassner G. [Signifi-cance of cutaneous microangiopathy for the pathogenesis of derma-titis in venous congestion due to chronic venous insufficiency]. Wien Med Wochenschr. 1994, 144:206-210.
75. Bates DO, Curry FE. Vascular endothelial growth factor increases hydraulic conductivity of isolated perfused microvessels. Am J Physiol. 1996, 271:2520-2528.
76. Shoab SS, Scurr JH, Coleridge-Smith PD. Increased plasma vascular endothelial growth factor among patients with chronic venous disease. J Vasc Surg. 1998, 28:535-540.
77. Shoab SS, Scurr JH, Coleridge-Smith PD. Plasma VEGF as a marker of therapy in patients with chronic venous disease treated with oral micronised flavonoid fraction-a pilot study. Eur J Vasc Endovasc Surg. 1999, 18:334-338.
78. Kim I, Moon SO, Kim SH, Kim HJ, Koh YS, Koh GY. Vascular endothelial growth factor expression of intercellular adhesion mole-cule 1 (ICAM-1) vascular cell adhesion molecule 1 (VCAM-1) and E-selectin through nuclear factor-kappa B activation in endothelial cells. J Biol Chem. 2001, 276:7614-7620.
79. Abumiya T, Sasaguri T, Taba Y, Miwa Y, Miyagi M. Shear stress induces expression of vascular endothelial growth factor receptor Flk-1/KDR through the CT-rich Sp1 binding site. Arterioscler Thromb Vasc Biol. 2002, 22:907-913.
80. Coleridge Smith PD. Leg Ulcers: Biochemical Factors. Phlebology. 2000, 15:156-161.
81. Pappas PJ, You R, Rameshwar P, Gorti R, DeFouw DO, Phillips CK, et al. Dermal tissue fibrosis in patients with chronic venous insuffi-ciency is associated with increased transforming growth factor-beta1 gene expression and protei. J Vasc Surg. 1999, 30:1129-1145.
82. McCord JM. Oxygen-derived radicals: A link between reperfusion injury and inflammation. Fed Proceed. 1987, 46:2402-2406.
83. Yamakawa Y, Takano M, Patel M, Tien N, Takada T, Bulkley GB. Interaction of platelet activating factor reactive oxygen species gen-erated by xanthine oxidase and leukocytes in the generation of hepatic injury after shock/resuscitation. Annals of Surgery. 2000, 231:387-398.
84. Lefer AM, Lefer DJ. Pharmacology of the endothelium in ischemia-reperfusion and circulatory shock. Ann Rev Pharm Tox. 1993, 33:71-90.
85. Smedegard G, Cui LX, Hugli TE Endotoxin-induced shock in the rat. A role for C5a. American Journal of Pathology 1989, 135:489-497.
86. Zanotti S, Kumar A. Cytokine modulation in sepsis and septic shock. Expert Opin Investig Drugs. 2002, 11:1061-1075.
87. Alvarez A, Hermenegildo C, Issekutz AC, Esplugues JV, Sanz MJ. Estrogens inhibit angiotensin II-induced leukocyte-endothelial cell interactions in vivo via rapid endothelial nitric oxide synthase and cyclooxygenase activa. Circ Res. 2002, 91:1142-1150.
88. Zimmerman GA, McIntyre TM, Prescott SM. Adhesion and signaling in vascular cell-cell interactions. J Clin Investi. 1996, 98:1699-1702.
89. Blake DR, Winyard PG, Marok R. The contribution of hypoxia-reperfusion injury to inflammatory synovitis: The influence of re-active oxygen intermediates on the transcriptional control of in. Ann N Y Acad Sci. 1994, 723:308-317.
90. Altay T, Gonzales ER, Park TS, Gidday JM. Cerebrovascular inflam-mation after brief episodic hypoxia: Modulation by neuronal and endothelial nitric oxide synthase. J Appl Physiol. 2004, 96:1223-1230. discussion 1196.
91. Shah S, Allen J, Wood JG, Gonzalez NC. Dissociation between skel-etal muscle microvascular PO2 and hypoxia-induced microvascular inflammation. J Appl Physiol. 2003, 94:2323-2329.
92. Whalen MJ, Carlos TM, Clark RS, Marion DW, DeKosky ST, Heineman S, et al. The effect of brain temperature on acute inflam-mation after traumatic brain injury in rats. J Neurotrauma. 1997, 14:561-572.
93. Kessler F, Schmidt KL. Thermometry in experimental inflammation. II. Studies of the effect of local cold application on the skin tempera-ture of the rat's paw in experimental inflam. Z Rheumatol. 1984, 43:83-88.
94. Miller AP, Feng W, Xing D, Weathington NM, Blalock JE, Chen YF, Oparil S. Estrogen modulates inflammatory mediator expression and neutrophil chemotaxis in injured arteries. Circulation. 2004, 110:1664-1669.
95. Chen D, Xu X, Cheon YP, Bagchi MK, Bagchi IC. Estrogen induces expression of secretory leukocyte protease inhibitor in rat uterus. Biol Reprod. 2004, 71:508-514.
96. Thongngarm T, Jenkins JK, Ndebele K, McMurray RW. Estrogen and progesterone modulate monocyte cell cycle progression and apopto-sis. Am J Reprod Immunol. 2003, 49:129-138.
97. Tibbetts TA, Conneely OM, O'Malley BW. Progesterone via its receptor antagonizes the pro-inflammatory activity of estrogen in the mouse uterus. Biol Reprod. 1999, 60:1158-1165.
98. Okouchi M, Okayama N, Shimizu M, Omi H, Fukutomi T, Itoh M. High insulin exacerbates neutrophil-endothelial cell adhesion through endothelial surface expression of intercellular adhesion molecule-1 via activation of protein kinase C and mitogen-activated protein kinase. Diabetologia. 2002, 45:556-559.
99. Beebe-Dimmer JL, Pfeifer JR, Engle JS, Schottenfeld D. The epide-miology of chronic venous insufficiency and varicose veins. Ann Epidemiol. 2005, 15:175-184.
100. Golledge J, Quigley FG. Pathogenesis of varicose veins. Eur J Vasc Endovasc Surg. 2003, 25:319-324.
101. Carpentier PH. Epidemiology and physiopathology of chronic venous leg diseases. Rev Prat. 2000, 50:1176-1181.
102. Callejas JM, Manasanch J. Epidemiology of chronic venous insuffi-ciency of the lower limbs in the primary care setting. Int Angiol. 2004, 23:154-163.
103. Kurz X, Kahn SR, Abenhaim L, Clement D, Norgren L, Baccaglini U, et al. Chronic venous disorders of the leg: Epidemiology outcomes diagnosis management. Summary of an evidence-based report of the VEINES task force. Venous Insufficiency Epidemiologic and Economic Studies. Int Angiol. 1999, 18:83-102.
104. Junger M, Steins A, Hahn M, Hafner HM. Microcirculatory dysfunc-tion in chronic venous insufficiency (CVI). Microcirculation. 2000, 7:3-12.
105. Herrick SE, Sloan P, McGurk M, Freak L, McCollum CN, Ferguson MW. Sequential changes in histologic pattern and extracellular matrix deposition during the healing of chronic venous ulcers. Am J Pathol. 1992, 141:1085-1095.
106. Fung YC Biodynamics: Circulation 1984, Springer-Verlag, New York.
107. Blatnick J, Sung LA, Schmid-Schönbein GW. The influence of fluid shear stress on embryonic primary capillary plexus remodeling. Biomech Model Mechanobiol. 2005, 4:211-220.
108. Price RJ, Less JR, Van Gieson EJ, Skalak TC Hemodynamic stresses and structural remodeling of anastomosing arteriolar networks: Design principles of collateral arterioles. Microcirculation. 2002, 9:111-124.
109. Fukuda S, Hashimoto N, Naritomi H, Nagata I, Nozaki K, Kondo S, et al. Prevention of rat cerebral aneurysm formation by inhibition of nitric oxide synthase. Circulation. 2000, 101:2532-2538.
110. Barbee KA. Role of subcellular shear-stress distributions in endothe-lial cell mechanotransduction. Ann Biomed Eng. 2002, 30:472-482.
111. Davies PF. Flow-mediated endothelial mechanotransduction. Physiol Rev. 1995, 75:519-560.
112. Davies PF, Barbee KA, Volin MV, Robotewskyj A, Chen J, Joseph L, et al. Spatial relationships in early signaling events of flow-mediated endothelial mechanotransduction. Annu Rev Physiol. 1997, 59:527-549.
113. Davies PF, Polacek DC, Shi C, Helmke BP The convergence of haemodynamics genomics and endothelial structure in studies of the focal origin of atherosclerosis. Biorheology. 2002, 39:299-306.
114. Helmke BP. Molecular control of cytoskeletal mechanics by hemo-dynamic forces. Physiology (Bethesda) 2005, 20:43-53.
115. Kakisis JD, Liapis CD, Sumpio BE. Effects of cyclic strain on vas-cular cells. Endothelium. 2004, 11:17-28.
116. Muller S, Labrador V, Da Isla N, Dumas D, Sun R, Wang X, et al. From hemorheology to vascular mechanobiology: An overview. Clin Hemorheol Microcirc. 2004, 30:185-200.
117. Resnick N, Yahav H, Shay-Salit A, Shushy M, Schubert S, Zilberman LC, Wofovitz E. Fluid shear stress and the vascular endothelium: For better and for worse. Prog Biophys Mol Biol. 2003, 81:177-199.
118. Shyy JY. Mechanotransduction in endothelial responses to shear stress: Review of work in Dr. Chien's laboratory. Biorheology 2001, 38:109-117.
119. Shyy JY, Chien S Role of integrins in endothelial mechanosensing of shear stress. Circ Res. 2002, 91:769-775.
120. Takahashi M, Ishida T, Traub O, Corson MA, Berk BC. Mechano-transduction in endothelial cells: Temporal signaling events in response to shear stress. J Vasc Res. 1997, 34:212-219.
121. Berk BC, Corson MA, Peterson TE, Tseng H. Protein kinases as mediators of fluid shear stress stimulated signal transduction in endothelial cells: A hypothesis for calcium-dependent and calcium-independent events activated by flow. J Biomech. 1995, 28:1439-1450.
122. Owatverot TB, Oswald SJ, Chen Y, Wille JJ, Yin FC. Effect of combined cyclic stretch and fluid shear stress on endothelial cell morphological responses. J Biomech Eng. 2005, 127:374-382.
123. Kohler R, Schonfelder G, Hopp H, Distler A, Hoyer J. Stretch-activated cation channel in human umbilical vein endothelium in normal pregnancy and in preeclampsia. J Hypertens. 1998, 16:1149-1156.
124. Sasamoto A, Nagino M, Kobayashi S, Naruse K, Nimura Y, Sokabe M. Mechanotransduction by integrin is essential for IL-6 secretion from endothelial cells in response to uniaxial continuous stretch. Am J Physiol Cell Physiol. 2005, 288:1012-1022.
125. Sipkema P, van der Linden PJ, Westerhof N, Yin FC. Effect of cyclic axial stretch of rat arteries on endothelial cytoskeletal morphology and vascular reactivity. J Biomech. 2003, 36:653-659.
126. Sokabe M, Naruse K, Sai S, Yamada T, Kawakami K, Inoue M, Murase K, Miyazu M. Mechanotransduction and intracellular signal-ing mechanisms of stretch-induced remodeling in endothelial cells. Heart Vessels. 1997, (. Suppl 12):191-193.
127. Tanabe Y, Saito M, Ueno A, Nakamura M, Takeishi K, Nakayama K. Mechanical stretch augments PDGF receptor beta expression and protein tyrosine phosphorylation in pulmonary artery tissue and smooth muscle cells. Mol Cell Biochem. 2000, 215:103-113.
128. Shin HY, Gerritsen ME, Bizios R. Regulation of endothelial cell proliferation and apoptosis by cyclic pressure. Ann Biomed Eng. 2002, 30:297-304.
129. Shin HY, Schwartz EA, Bizios R, Gerritsen ME. Receptor-mediated basic fibroblast growth factor signaling regulates cyclic pressure-induced human endothelial cell proliferation. Endothelium. 2004, 11:285-291.
130. Moazam F, DeLano FA, Zweifach BW, Schmid-Schönbein GW. The leukocyte response to fluid stress. Proc Natl Acad Sci USA. 1997, 94:5338-5343.
131. Coughlin MF, Schmid-Schönbein GW. Pseudopod projection and cell spreading of passive leukocytes in response to fluid shear stress. Biophys J. 2004, 87:2035-2042.
132. Fukuda S, Schmid-Schönbein GW. Regulation of CD18 expression on neutrophils in response to fluid shear stress. Proc Natl Acad Sci USA. 2003, 100:13152-13157.
133. Fukuda S, Yasu T, Predescu DN, Schmid-Schönbein GW. Mecha-nisms for regulation of fluid shear stress response in circulating leu-kocytes. Circulation Research. 2000, 86:13-18.
134. Kaazempur-Mofrad MR, Ethier CR. Mass transport in an anatomi-cally realistic human right coronary artery. Ann Biomed Eng. 2001, 29:121-127.
135. David G, Humphrey JD. Further evidence for the dynamic stability of intracranial saccular aneurysms. J Biomech. 2003, 36:1143-1150.
136. Di Martino ES, Guadagni G, Fumero A, Ballerini G, Spirito R, Biglioli P, Redaelli A. Fluid-structure interaction within realistic three-dimensional models of the aneurysmatic aorta as a guidance to assess the risk of rupture of the aneurysm. Med Eng Phys. 2001, 23:647-655.
137. Leung J, Wright A, Cheshire N, Thom SA, Hughes AD, Xu XY. Flow patterns and wall shear stresses in patient-specific models of the abdominal aortic aneurysm. Stud Health Technol Inform. 2004, 103:235-242.
138. Mori D, Yamaguchi T. Computational fluid dynamics modeling analysis of the effect of 3-D distortion of the human aortic arch. Comput Methods Biomech Biomed Engin. 2002, 5:249-260.
139. Shah AD, Humphrey JD. Finite strain elastodynamics of intracranial saccular aneurysms. J Biomech. 1999, 32:593-599.
140. Kistler EB, Hugli TE, Schmid-Schönbein GW. The pancreas as a source of cardiovascular cell activating factors. Microcirculation. 2000, 7:183-192.
141. Kramp WJ, Waldo S, Schmid-Schönbein GW, Hoyt D, Coimbra R, Hugli TE. Characterization of two classes of pancreatic shock factors: Functional differences exhibited by hydrophilic and hydrophobic shock factors. Shock. 2003, 20:356-362.
142. Waldo SW, Rosario HS, Penn AH, Schmid-Schönbein GW. Pancre-atic digestive enzymes are potent generators of mediators for leuko-cyte activation and mortality. Shock. 2003, 20:138-143.
143. Cordts PR, Kaminski MV, Raju S, Clark MR Woo KM. Could gut-liver function derangements cause chronic venous insufficiency? Vasc Surg. 2001, 35:107-114.
144. Sansilvestri-Morel P, Rupin A, Badier-Commander C, Kern P, Fabiani JN, Verbeuren TJ, Vanhoutte PM. Imbalance in the synthesis of collagen type I and collagen type III in smooth muscle cells derived from human varicose veins. J Vasc Res. 2001, 38:560-568.
145. Sansilvestri-Morel P, Rupin A, Badier-Commander C, Fabiani JN, Verbeuren TJ. Chronic venous insufficiency: Dysregulation of col-lagen synthesis. Angiology. 2003, 54(Suppl 1):13-18.
146. Badier-Commander C, Verbeuren T, Lebard C, Michel JB, Jacob MP. Increased TIMP/MMP ratio in varicose veins: A possible explana-tion for extracellular matrix accumulation. J Pathol. 2000, 192:105-112.
147. Bujan J, Jurado F, Gimeno MJ, Garcia-Honduvilla N, Pascual G, Jimenez J, Bellon JM. Changes in metalloproteinase (MMP-1 MMP-2) expression in the proximal region of the varicose saphenous vein in young subjects. Phlebology. 2000, 15:64-70.
148. Pascarella L, Penn A, Schmid-Schönbein GW. Venous hypertension and the inflammatory cascade: Major manifestations and trigger mechanisms. Angiology. 2005, 56(Suppl 1):3-10.